|
Report Date : |
17.09.2013 |
IDENTIFICATION DETAILS
|
Name : |
ASTRON LIMITED |
|
|
|
|
Registered Office : |
# 688, Galle Road, Ratmalana |
|
|
|
|
Country : |
Sri Lanka |
|
|
|
|
Date of Incorporation : |
03.11.1993 |
|
|
|
|
Com. Reg. No.: |
N (PBS) 439 |
|
|
|
|
Legal Form : |
Public Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturing, Importing and Marketing of all types of Pharmaceuticals |
|
|
|
|
No. of Employees : |
600 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Sri Lanka |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SRI LANKA - ECONOMIC OVERVIEW
Sri Lanka continues to
experience strong economic growth following the end of the 26-year conflict with
the Liberation Tigers of Tamil Eelam (LTTE). The government has been pursuing
large-scale reconstruction and development projects in its efforts to spur
growth in war-torn and disadvantaged areas, develop small and medium
enterprises and increase agricultural productivity. The government's high debt
payments and bloated civil service have contributed to historically high budget
deficits, but fiscal consolidation efforts and strong GDP growth in recent
years have helped bring down the government's fiscal deficit. However, low tax
revenues are a major concern. The 2008-09 global financial crisis and recession
exposed Sri Lanka''s economic vulnerabilities and nearly caused a balance of
payments crisis. Growth slowed to 3.5% in 2009. Economic activity rebounded
with the end of the war and an IMF agreement, resulting in two straight years
of 8% growth in 2010-11. Growth moderated to about 6% in 2012. Agriculture
slowed due to a drought and weak global demand affected exports and trade. In
early 2012, Sri Lanka floated the rupee, resulting in a sharp depreciation, and
took steps to curb imports. A large trade deficit remains a concern. Strong
remittances from Sri Lankan workers abroad have helped to offset the trade
deficit
|
Source
: CIA |
|
Name of Subject of Inquiry |
: |
ASTRON LIMITED
|
|
Legal Form & Status |
: |
Public Limited Liability Company. (In Operation) |
|
Managing
Director |
: |
Marise
Bernadette Deckker |
|
Primary Line of Business |
: |
Manufacturers, Importers and Distributors of
Pharmaceuticals |
|
Place of
Business & Factory |
: |
# 688, Galle Road, Ratmalana, Sri
Lanka Tel.
No: (00 94 11) 263 6741 / 556 6741 Fax No: (00 94 11) 263 6173 / 556 6789 Email: astron@astron.lk |
|
No of Employees |
: |
Approximately
600 |
|
Registration No |
: |
N (PBS) 439 |
|
|
Date of Registration |
: |
03rd November 1993 |
|
|
Re-registration No |
|
PB 78 |
|
|
Date of Re-registration |
|
06th December 2007 |
|
|
Registered Office |
: |
|
|
|
Board of Directors As At 11th June 2013 |
: |
Marise Bernadette Deckker |
Managing Director |
|
Kangaratnam Manickavasagar |
Director |
||
|
Harrin Dhammika Jayasekera |
Director |
||
|
P.S. Ranjit Fernando |
Director |
||
|
N. Shanthi Goonawardene |
Director |
||
|
M. Farhad Cassim |
Director |
||
|
D.A.S. Warna Athukorala |
Director |
||
|
R. Michael De Zilwa |
Director |
||
|
Issued Share Capital |
: |
Rs. 57,145,500.00 |
|
|
Nominal Value of Share |
: |
Rs. 10.00 |
|
|
Major Share Holders As At 07th June 2012 |
: |
Share Holders |
No. Of Shares |
|
Marise Bernadette Deckker |
2,948,860 |
||
|
K. Manickavasagar |
401,045 |
||
|
A. Z. Fazeel |
401,045 |
||
|
H. D. Jayasekara |
401,045 |
||
|
H. L. De mel |
40 |
||
|
Astron Employee Share Trust |
1,562,500 |
||
|
Auditors |
: |
KPMG Ford Rhodes Thornton
& Company |
|
|
Company Secretaries |
: |
Kumarinio Nadisha
Samarasekera |
|
|
Bankers |
: |
DFCC Bank |
|
|
|
30th November 2012 Rs. |
30th November 2011 Rs. |
||
|
A |
Revenue |
: |
1,343,578,720 |
1,189,412,419 |
|
B |
Cost
of Sales |
: |
(738,040,241) |
(628,636,943) |
|
C |
Gross Profit |
: |
605,538,479 |
560,775,476 |
|
D |
Other Income |
: |
11,943,118 |
16,815,856 |
|
E |
Administration Expense |
: |
(104,123,298) |
(87,788,038) |
|
F |
Distribution Expense |
: |
(345,768,172) |
(303,469,559) |
|
G |
Profit from Operations |
|
167,590,127 |
186,333,735 |
|
H |
Finance Expense |
: |
(14,427,448) |
(11,051,119) |
|
I |
Net Profit / (Loss) before Tax |
: |
153,162,679 |
175,282,616 |
|
J |
Taxation |
: |
(36,287,266) |
(42,593,372) |
|
K |
Net Profit / (Loss) After Tax: |
: |
116,875,414 |
132,689,244 |
|
|
30th November 2012 Rs. |
30th November 2011 Rs. |
||
|
a) |
Non-current Assets |
: |
504,037,794 |
443,309,716 |
|
b) |
Current Assets |
: |
501,248,883 |
451,184,270 |
|
c) |
Current Liability |
: |
208,051,697 |
215,265,092 |
|
d) |
Non-current liability |
: |
144,463,331 |
93,361,924 |
|
e) |
Total Liabilities |
: |
352,515,028 |
308,627,016 |
|
f) |
Total Assets |
: |
1,005,286,677 |
894,493,987 |
|
g) |
Net Worth |
: |
652,771,649 |
585,866,971 |

Company Logo
·
History.
The Subject Company ASTRON
LIMITED is a Public Limited Liability Company incorporated on 03rd
Nov 1993 under registration number N (PBS) 439 and then company was
re-registered on 06th December 2007 under registration number
PB 78.
The subject
company was earlier known as ASTRON HOLDINGS LTD and changed to
ASTRON LTD on 07th April 1995.
·
Location.
The Subject
Company is located at the client # 688, Galle Road, Ratmalana, Sri Lanka
·
Operational
Details.
General
The subject company primary
line of business is manufacturing,
Importing and Marketing of all types of Pharmaceuticals which are distributed islandwide to
appointed dealers of the subject company.
The subject
company has earned certified ISO 22000, HACCP
The subject company
has competition from the state Pharmaceuticals Corporation coming under the
Ministry of Health. The subject company has their own marketing team to promote
their products through Doctors, Dispensaries, Hospitals and Coordinating
supplies to dealers. The subject company outside appearance is very attractive
and maintenance, cleanliness, housekeeping and safety procedures are given high
priority.
Products
Antibiotics
Cough preparation
Anti inflammatory
Antibiotic
Anthelmintic
Vitamins
Minerals
Antihistamine
Anti acne preparation
Anti diabetic
Analgesic and antipyretic
etc…..


Astron is a member
of the following associations:
Brands
Astron Pharmaceuticals
Astron Consumer
Astron Animal Health
Import Countries
India, USA and
Netherlands.
No of Employees
Approximately 600
·
Financial Data
Received from subject company annual report
·
Trade references
Sri Lanka Pharmaceutical Manufacturers
Association
Sri Lanka Chamber of Pharmaceutical
Industries
Sri Lanka Poultry Industry Association
Ceylon Chamber of Commerce
·
Credit
Recommendations
Since no financial
information has been forthcoming from the company, it is not possible to
comment on the merits or otherwise of the company.
No computerised
data bases exist to make checks whether the partners or the company has any
legal action or lawsuit initiated against any of them but informal (but not
in-depth) checks do not indicate any such cases in the public knowledge.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.48 |
|
|
1 |
Rs.99.66 |
|
Euro |
1 |
Rs.83.49 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.